nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
|
Fehniger, Todd A. |
|
|
117 |
6 |
p. 1828-1833 |
artikel |
2 |
A role for Blimp1 in the transcriptional network controlling natural killer cell maturation
|
Kallies, Axel |
|
|
117 |
6 |
p. 1869-1879 |
artikel |
3 |
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway
|
Mao, Xinliang |
|
|
117 |
6 |
p. 1986-1997 |
artikel |
4 |
Bordon V, Gennery AR, Slatter MA, et al. Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation. Blood. 2010;116(1):27-35.
|
|
|
|
117 |
6 |
p. 2077 |
artikel |
5 |
CD9 phones home with a TEM of its own
|
Brown, Alexander W. |
|
|
117 |
6 |
p. 1775-1776 |
artikel |
6 |
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities
|
Chiorazzi, Nicholas |
|
|
117 |
6 |
p. 1781-1791 |
artikel |
7 |
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
|
Montesinos, Pau |
|
|
117 |
6 |
p. 1799-1805 |
artikel |
8 |
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
|
Kim, Seok Jin |
|
|
117 |
6 |
p. 1958-1965 |
artikel |
9 |
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP
|
Ju, Wei |
|
|
117 |
6 |
p. 1938-1946 |
artikel |
10 |
Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications
|
Billot, Katy |
|
|
117 |
6 |
p. 1917-1927 |
artikel |
11 |
Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives
|
Bianchini, Elsa P. |
|
|
117 |
6 |
p. 2054-2060 |
artikel |
12 |
Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells
|
Choi, Hak-Jong |
|
|
117 |
6 |
p. 1880-1887 |
artikel |
13 |
Disruption of Src function potentiates Chk1-inhibitor–induced apoptosis in human multiple myeloma cells in vitro and in vivo
|
Dai, Yun |
|
|
117 |
6 |
p. 1947-1957 |
artikel |
14 |
Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women
|
Kolte, Lilian |
|
|
117 |
6 |
p. 1861-1868 |
artikel |
15 |
Editorial Board
|
|
|
|
117 |
6 |
p. i |
artikel |
16 |
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
|
Jaccard, Arnaud |
|
|
117 |
6 |
p. 1834-1839 |
artikel |
17 |
Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
|
Wang, Xiuli |
|
|
117 |
6 |
p. 1888-1898 |
artikel |
18 |
Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection
|
Clark, Stephen R. |
|
|
117 |
6 |
p. 2033-2043 |
artikel |
19 |
Fitness without exhaustion
|
Perreault, Claude |
|
|
117 |
6 |
p. 1776 |
artikel |
20 |
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD
|
Flood, Veronica H. |
|
|
117 |
6 |
p. e67-e74 |
artikel |
21 |
Gene profiling of Graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene
|
Charfi, Cyndia |
|
|
117 |
6 |
p. 1899-1910 |
artikel |
22 |
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
|
Slager, Susan L. |
|
|
117 |
6 |
p. 1911-1916 |
artikel |
23 |
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
|
Li, Qing |
|
|
117 |
6 |
p. 2022-2032 |
artikel |
24 |
Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities
|
Marcucci, Fabrizio |
|
|
117 |
6 |
p. 1792-1798 |
artikel |
25 |
High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcγ receptors on monocytes in patients with primary immune thrombocytopenia
|
Liu, Xin-guang |
|
|
117 |
6 |
p. 2061-2069 |
artikel |
26 |
High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma
|
Clark, Rachael A. |
|
|
117 |
6 |
p. 1966-1976 |
artikel |
27 |
Interleukin-7 induces HIV type 1 R5-to-X4 switch
|
Brieu, Natalie |
|
|
117 |
6 |
p. 2073-2074 |
artikel |
28 |
JAK blockade and HTLV
|
Ratner, Lee |
|
|
117 |
6 |
p. 1771-1772 |
artikel |
29 |
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis
|
Eichhorst, Barbara F. |
|
|
117 |
6 |
p. 1817-1821 |
artikel |
30 |
Lymphomas differ in their dependence on Epstein-Barr virus
|
Vereide, David T. |
|
|
117 |
6 |
p. 1977-1985 |
artikel |
31 |
Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit
|
Gerbaulet, Alexander |
|
|
117 |
6 |
p. 2012-2021 |
artikel |
32 |
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
|
Castellino, Sharon M. |
|
|
117 |
6 |
p. 1806-1816 |
artikel |
33 |
Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival
|
Steinbrunn, Torsten |
|
|
117 |
6 |
p. 1998-2004 |
artikel |
34 |
Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma
|
Chevillard, Grégory |
|
|
117 |
6 |
p. 2005-2008 |
artikel |
35 |
Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome
|
Darghouth, Dhouha |
|
|
117 |
6 |
p. e57-e66 |
artikel |
36 |
Predicting response in CML
|
Guilhot, François |
|
|
117 |
6 |
p. 1773-1774 |
artikel |
37 |
Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure
|
Jabbour, Elias |
|
|
117 |
6 |
p. 1822-1827 |
artikel |
38 |
Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis
|
Leung, Roland |
|
|
117 |
6 |
p. 2044-2053 |
artikel |
39 |
Sieniawski M, Angamuthu N, Boyd K, et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010;115(18):3664-3670.
|
|
|
|
117 |
6 |
p. 2077 |
artikel |
40 |
Sobering realities of surviving Hodgkin Lymphoma
|
Dunleavy, Kieron |
|
|
117 |
6 |
p. 1772-1773 |
artikel |
41 |
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver
|
Lisman, Ton |
|
|
117 |
6 |
p. 2070-2072 |
artikel |
42 |
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy
|
Ghosh, Asish K. |
|
|
117 |
6 |
p. 1928-1937 |
artikel |
43 |
The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells
|
Leung, Kam Tong |
|
|
117 |
6 |
p. 1840-1850 |
artikel |
44 |
The times they are a-changin'
|
Estey, Elihu |
|
|
117 |
6 |
p. 1774-1775 |
artikel |
45 |
TLR2-dependent pathway of heterologous down-modulation for the CC chemokine receptors 1, 2, and 5 in human blood monocytes
|
Fox, James M. |
|
|
117 |
6 |
p. 1851-1860 |
artikel |
46 |
Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2
|
Schaub, Franz X. |
|
|
117 |
6 |
p. 2075-2076 |
artikel |
47 |
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
|
Avet-Loiseau, Hervé |
|
|
117 |
6 |
p. 2009-2011 |
artikel |
48 |
What keeps the power on in lymphomas?
|
Hammerschmidt, Wolfgang |
|
|
117 |
6 |
p. 1777-1778 |
artikel |
49 |
Who controls the controllers?
|
Monagle, Paul |
|
|
117 |
6 |
p. 1778-1779 |
artikel |